Work

Associations of plasma concentrations of MGO-ALB243-249, a signature peptide of glycated albumin, with the risk of cardiovascular death in type 2 diabetes

Year: 2024

Type: article

Study design: Observational Study

Source: Atherosclerosis

DOI: 10.1016/j.atherosclerosis.2024.118326

Authors: Arsênio Oliveira, Chloé Chevalier, Loïc Thenaisie, Matthieu Wargny, Victoria Pakulska, Yohann Couté, Pierre-Jean Saulnier, Alice Pinheiro, Cédric Le May, Bertrand Cariou, Samy Hadjadj, Mikaël Croyal

Institutions: Institut du Thorax, Nantes Université, Centre National de la Recherche Scientifique, Inserm, Centre Hospitalier Universitaire de Nantes, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, CEA Grenoble, Université Grenoble Alpes, Université de Poitiers, Centre Hospitalier Universitaire de Poitiers

Language: English

Topic: Advanced Glycation End Products research

Subfield: Clinical Biochemistry

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4401599990

FWCI:

Cites:

Cited by:

Related to: 10